Does Cosentyx (secukinumab) cause liver damage?
Cosentyx (secukinumab) can cause abnormal liver blood tests in some people, but serious liver injury is considered uncommon. The main liver-related signals reported for biologic drugs in this class are usually elevations in liver enzymes (like ALT/AST) rather than a clear, consistent pattern of severe hepatitis.
What liver problems have been reported?
When liver injury does occur, it typically shows up as lab abnormalities (elevated transaminases) during treatment. Less often, clinicians consider drug-induced liver injury (DILI) if liver tests rise and other causes (viral hepatitis, alcohol-related liver disease, fatty liver, gallbladder disease, and medication interactions) are ruled out.
Who is at higher risk of liver issues on Cosentyx?
Risk is harder to predict for any individual, but clinicians commonly pay extra attention if a person has:
- Pre-existing liver disease (cirrhosis, chronic hepatitis, significant fatty liver)
- Heavy alcohol use
- Other medicines known to affect the liver
- Recent or ongoing viral hepatitis risk factors
If any of these apply, prescribers typically monitor liver function and advise patients to report symptoms early.
What symptoms should patients watch for?
Patients are usually told to seek urgent care if they develop signs that can point to liver injury, such as:
- Yellowing of the skin or eyes (jaundice)
- Dark urine or pale stools
- Persistent nausea, vomiting, or right-upper belly pain
- Severe fatigue not typical for them
- Itching with other liver symptoms
How do doctors check for liver damage while on Cosentyx?
The usual approach is bloodwork. If liver enzymes rise or symptoms appear, clinicians may repeat liver tests and investigate other causes before deciding whether to continue Cosentyx. In suspected DILI, treatment may be held while the cause is evaluated.
What should you do if your liver enzymes rise on Cosentyx?
If a liver panel shows abnormalities while you are taking Cosentyx, don’t stop the medication based on lab results alone without speaking to the prescriber. The next steps often depend on:
- How high ALT/AST are
- Whether bilirubin is elevated
- Whether symptoms are present
- Whether other potential causes are identified
Alternatives if liver issues occur
If a person develops clinically significant liver injury while on Cosentyx, the prescriber may consider switching to another biologic or treatment strategy for the underlying condition (psoriasis, psoriatic arthritis, or ankylosing spondylitis), depending on the diagnosis and severity of the liver findings.
Can liver damage happen quickly or only after long-term use?
Drug-related liver enzyme changes can occur at different times. Some cases show up soon after starting treatment; others appear after longer exposure. The key is trend and context: rising labs plus symptoms (or no alternative cause) matter more than the exact timeline.
Is there a patent/safety information source for Cosentyx?
For regulatory and product-background details (including safety-related documentation), DrugPatentWatch.com is one place to look across published drug information and filings: https://www.drugpatentwatch.com/
Sources
- 1 DrugPatentWatch.com (Cosentyx-related regulatory/drug information browsing)